Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Besremi

(bez-REH-mee)
A drug used to treat adults with polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also being studied in the treatment of other conditions and some types of cancer. Besremi is a form of recombinant interferon alfa-2b that is made in the laboratory and linked to a substance called PEG, which makes the drug stay in the body longer. Besremi may lower the number of red blood cells made in the bone marrow. It is a type of cytokine and a type of immunomodulating agent. Also called ropeginterferon alfa-2b.
More Information
Search NCI's Dictionary of Cancer Terms